EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lipoprotein(a) is associated with a larger systemic burden of arterial calcification

Sunny S Singh iD, Janine E van der Toorn, Eric J G Sijbrands, Yolanda B de Rijke, Maryam Kavousi iD, Daniel Bos iD

European Heart Journal - Cardiovascular Imaging · 2023

DOI: 10.1093/ehjci/jead057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2023. Verfasst von Sunny S Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Coronary Artery Disease, Carotid Artery Diseases, Calcinosis, Vascular Calcification. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alzheimer's Association, Erasmus Medical Center and Erasmus University, Organization for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Lipoprotein(a) [Lp(a)] is a genetically determined risk factor for cardiovascular disease. However, population-based evidence on the link between Lp(a) and subclinical arteriosclerosis is lacking. We assessed associations of Lp(a) concentrations with arteriosclerosis in multiple arteries. Methods and results From the population-based Rotterdam study, 2354 participants (mean age: 69.5 years, 52.3% women) underwent non-contrast computed tomography to assess arterial calcification as a hallmark of arteriosclerosis. We quantified the volume of coronary artery calcification (CAC), aortic arch calcification (AAC), extracranial (ECAC), and intracranial carotid artery calcification (ICAC). All participants underwent blood sampling, from which plasma Lp(a) concentrations were derived. The association of plasma Lp(a) levels was assessed with calcification volumes and with severe calcification (upper quartile of calcification volume) using sex-stratified multivariable linear and logistic regression models. Higher Lp(a) levels were associated with larger ln-transformed volumes of CAC [fully adjusted beta 95% confidence interval (CI) per 1 standard deviation (SD) in women: 0.09, 95% CI 0.04–0.14, men: 0.09, 95% CI 0.03–0.14], AAC (women: 0.06, 95% CI 0.01–0.11, men: 0.09, 95% CI 0.03–0.14), ECAC (women: 0.07, 95% CI 0.02–0.13, men: 0.08, 95% CI 0.03–0.14), and ICAC (women: 0.09, 95% CI 0.03–0.14, men: 0.05, 95% CI −0.02 to 0.11]. In the highest Lp(a) percentile, severe ICAC was most prevalent in women [fully adjusted odds ratio (OR) 2.41, 95% CI 1.25–4.63] and severe AAC in men (fully adjusted OR 3.29, 95% CI 1.67–6.49).

Conclusion

Higher Lp(a) was consistently associated with a larger calcification burden in all major arteries. The findings of this study indicate that Lp(a) is a systemic risk factor for arteriosclerosis and thus potentially an effective target for treatment. Lp(a)-reducing therapies may reduce the burden from arteriosclerotic events throughout the arterial system. Translational perspective In 2354 participants from the Rotterdam study, we assessed the link between Lp(a) concentrations and arterial calcifications, as proxy for arteriosclerosis, in major arteries. We found that higher Lp(a) levels were consistently associated with larger volumes of calcification in the coronary arteries, aortic arch, extracranial carotid arteries, and intracranial carotid arteries. The findings of our study indicate that Lp(a) is a systemic risk factor for arteriosclerosis, suggesting that the systemic burden of arteriosclerosis throughout the arterial system could be reduced by targeting Lp(a).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseCarotid Artery DiseasesCalcinosisVascular CalcificationMaleHumansFemaleAgedLipoprotein(a)Risk Factors

Stichwörter der Autor:innen

Lp(a)arterial calcificationarteriosclerosislipoprotein(a)risk factors

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Department of Epidemiology, Erasmus MC, University Medical Centre, PO Box 2040, Rotterdam 3000 CA, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Centre, PO Box 2040, Rotterdam 3000 CA, The Netherlands.
  • Department of Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Sunny S Singh, Maryam Kavousi, Daniel Bos

Förderung

  • Alzheimer's Association
  • Erasmus Medical Center and Erasmus University
  • Organization for Scientific Research
  • Netherlands Organization for Health Research and Development
  • Research Institute for Diseases in the Elderly
  • Netherlands Genomics Initiative
  • Ministry of Education, Culture, and Science
  • Ministry of Health, Welfare, and Sports

Zitieren

APA

Singh, S. S., van der Toorn, J. E., Sijbrands, E. J. G., de Rijke, Y. B., Kavousi, M., & Bos, D. (2023). Lipoprotein(a) is associated with a larger systemic burden of arterial calcification. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead057

Vancouver

Singh SS, van der Toorn JE, Sijbrands EJG, de Rijke YB, Kavousi M, Bos D. Lipoprotein(a) is associated with a larger systemic burden of arterial calcification. European Heart Journal - Cardiovascular Imaging. 2023. doi:10.1093/ehjci/jead057

BibTeX
@article{Singh2023,
  author = {Singh, Sunny S and van der Toorn, Janine E and Sijbrands, Eric J G and de Rijke, Yolanda B and Kavousi, Maryam and Bos, Daniel},
  title = {Lipoprotein(a) is associated with a larger systemic burden of arterial calcification},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2023},
  doi = {10.1093/ehjci/jead057}
}
Kostenlos starten →